These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 1107120

  • 1. Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets.
    Schauder P, Frerichs H.
    Diabetologia; 1975 Aug; 11(4):301-5. PubMed ID: 1107120
    [Abstract] [Full Text] [Related]

  • 2. Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administrationof high or low tolbutamide doses.
    Schauder P, Arends J, Frerichs H.
    Metabolism; 1977 Jan; 26(1):9-15. PubMed ID: 319321
    [Abstract] [Full Text] [Related]

  • 3. Insulin release from pancreatic islets of fetal rats mediated by leucine b-BCH, tolbutamide, glibenclamide, arginine, potassium chloride, and theophylline does not require stimulation of Ca2+ net uptake.
    Ammon HP, Glocker C, Waldner RG, Wahl MA.
    Cell Calcium; 1989 Jan; 10(6):441-50. PubMed ID: 2505929
    [Abstract] [Full Text] [Related]

  • 4. Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.
    Garcia SD, Jarrousse C, Rosselin G.
    J Clin Invest; 1976 Jan; 57(1):230-43. PubMed ID: 173741
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide.
    Verspohl EJ, Händel M, Hagenloh I, Ammon HP.
    Acta Diabetol Lat; 1982 Jan; 19(4):303-17. PubMed ID: 6758458
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS.
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and release of proinsulin and insulin by isolated rat islets of Langerhans.
    Tanese T, Lazarus NR, Devrim S, Recant L.
    J Clin Invest; 1970 Jul; 49(7):1394-404. PubMed ID: 4914679
    [Abstract] [Full Text] [Related]

  • 10. Appearance of glucose-induced insulin release in fetal rat beta-cells.
    Bergsten P, Aoyagi K, Persson E, Eriksson UJ, Hellerström C.
    J Endocrinol; 1998 Jul; 158(1):115-20. PubMed ID: 9713332
    [Abstract] [Full Text] [Related]

  • 11. Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.
    Kawazu S, Sener A, Couturier E, Malaisse WJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):277-83. PubMed ID: 6995864
    [Abstract] [Full Text] [Related]

  • 12. Cyclic nucleotides in pancreatic islets. Tolbutamide- and arginine-induced insulin release.
    Charles MA, Lawecki J, Steiner AL, Grodsky GM.
    Diabetes; 1976 Apr; 25(4):256-9. PubMed ID: 178555
    [Abstract] [Full Text] [Related]

  • 13. Chloride modulation of insulin release, 86Rb+ efflux, and 45Ca2+ fluxes in rat islets stimulated by various secretagogues.
    Tamagawa T, Henquin JC.
    Diabetes; 1983 May; 32(5):416-23. PubMed ID: 6341124
    [Abstract] [Full Text] [Related]

  • 14. Decreased pancreatic islet response to L-leucine in the spontaneously diabetic GK rat: enzymatic, metabolic and secretory data.
    Giroix MH, Saulnier C, Portha B.
    Diabetologia; 1999 Aug; 42(8):965-77. PubMed ID: 10491757
    [Abstract] [Full Text] [Related]

  • 15. Effects of tolbutamide pretreatment on the rate of conversion of newly synthesized proinsulin to insulin and the compartmental characteristics of insulin storage in isolated rat islets.
    Gold G, Pou J, Gishizky ML, Landahl HD, Grodsky GM.
    Diabetes; 1986 Jan; 35(1):6-12. PubMed ID: 3510140
    [Abstract] [Full Text] [Related]

  • 16. Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).
    Ammon HP.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Jan; 290(2-3):251-64. PubMed ID: 241943
    [Abstract] [Full Text] [Related]

  • 17. Relationship between glucose- and tolbutamide- induced insulin release and insulin content in single pancreatic rat islets.
    Steinke J, Patel TN, Ammon HP.
    Metabolism; 1972 May; 21(5):465-70. PubMed ID: 4552618
    [No Abstract] [Full Text] [Related]

  • 18. Regulation of energy metabolism in pancreatic islets by glucose and tolbutamide.
    Panten U, Zünkler BJ, Scheit S, Kirchhoff K, Lenzen S.
    Diabetologia; 1986 Sep; 29(9):648-54. PubMed ID: 3539682
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin inhibition of glucose-, tolbutamide-, theophylline, cytochalasin B-, and calcium-stimulated insulin release in monolayer cultures of rat endocrine pancreas.
    Fujimoto WY.
    Endocrinology; 1975 Dec; 97(6):1494-500. PubMed ID: 1107017
    [Abstract] [Full Text] [Related]

  • 20. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes.
    Giroix MH, Vesco L, Portha B.
    Endocrinology; 1993 Feb; 132(2):815-22. PubMed ID: 8425496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.